Literature DB >> 9988224

Expression of calpain I messenger RNA in human renal cell carcinoma: correlation with lymph node metastasis and histological type.

C Braun1, M Engel, M Seifert, B Theisinger, G Seitz, K D Zang, C Welter.   

Abstract

Calpain, also named CANP (for calcium-activated neutral protease), is an intracellular cytoplasmatic non-lysosomal cysteine endopeptidase that requires calcium ions for activity. Many substrates of the calpain isoenzymes, such as the transcription factors c-Fos and c-Jun, the tumor supressor protein p53, protein kinase C, pp60c-src and the adhesion molecule integrin, have been implicated in the pathogenesis of different human tumors, suggesting an important role of the calpains in malignant diseases. We now report differential expression of the calpain I gene (CL I) in a variety of tumors, extending our study to a larger series of renal cell carcinomas. Using Northern-blot analysis, we studied calpain I expression in 30 renal cell carcinomas as compared with matched healthy tissues. Tumor samples were classified according to their histological type: 21 clear cell carcinomas, 4 chromophobe carcinomas, 3 papillary carcinomas and 2 oncocytomas. In renal tumor samples, calpain I gene mRNA was expressed at highly variable levels, significantly depending on the different histological types. Moreover, there was a correlation of higher calpain I expression with increased malignancy: within the clear cell carcinoma subset, tumor samples with advanced nodal status (N1 and N2) showed a significantly higher calpain I expression than tumors without metastasis to regional lymph nodes. Our data suggest an important role of calpain isoenzymes in carcinogenesis and tumor progression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9988224     DOI: 10.1002/(sici)1097-0215(19990219)84:1<6::aid-ijc2>3.0.co;2-t

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

1.  Calpain 2 is required for glioblastoma cell invasion: regulation of matrix metalloproteinase 2.

Authors:  Hyo Sang Jang; Sangeet Lal; Jeffrey A Greenwood
Journal:  Neurochem Res       Date:  2010-08-21       Impact factor: 3.996

2.  Acute-phase protein α1-antitrypsin inhibits neutrophil calpain I and induces random migration.

Authors:  Mariam Al-Omari; Elena Korenbaum; Matthias Ballmaier; Ulrich Lehmann; Danny Jonigk; Dietmar J Manstein; Tobias Welte; Ravi Mahadeva; Sabina Janciauskiene
Journal:  Mol Med       Date:  2011-04-11       Impact factor: 6.354

3.  BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study.

Authors:  David M Gau; Jamie L Lesnock; Brian L Hood; Rohit Bhargava; Mai Sun; Kathleen Darcy; Soumya Luthra; Uma Chandran; Thomas P Conrads; Robert P Edwards; Joseph L Kelley; Thomas C Krivak; Partha Roy
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  v-Src-induced modulation of the calpain-calpastatin proteolytic system regulates transformation.

Authors:  N O Carragher; M A Westhoff; D Riley; D A Potter; P Dutt; J S Elce; P A Greer; M C Frame
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

5.  Calcium-induced cleavage of DNA topoisomerase I involves the cytoplasmic-nuclear shuttling of calpain 2.

Authors:  Shang-Min Chou; Ting-Hsiang Huang; Hsiang-Chin Chen; Tsai-Kun Li
Journal:  Cell Mol Life Sci       Date:  2010-11-18       Impact factor: 9.261

Review 6.  The calpain system and cancer.

Authors:  Sarah J Storr; Neil O Carragher; Margaret C Frame; Tim Parr; Stewart G Martin
Journal:  Nat Rev Cancer       Date:  2011-05       Impact factor: 60.716

7.  Calpain 9 as a therapeutic target in TGFβ-induced mesenchymal transition and fibrosis.

Authors:  David H Kim; James D Beckett; Varun Nagpal; Manuel A Seman-Senderos; Russell A Gould; Tyler J Creamer; Elena Gallo MacFarlane; Yichun Chen; Djahida Bedja; Jonathan T Butcher; Wayne Mitzner; Rosanne Rouf; Shoji Hata; Daniel S Warren; Harry C Dietz
Journal:  Sci Transl Med       Date:  2019-07-17       Impact factor: 17.956

Review 8.  Calpains as potential anti-cancer targets.

Authors:  Ludovic Leloup; Alan Wells
Journal:  Expert Opin Ther Targets       Date:  2011-01-19       Impact factor: 6.902

9.  Wnt5A activates the calpain-mediated cleavage of filamin A.

Authors:  Michael P O'Connell; Jennifer L Fiori; Katherine M Baugher; Fred E Indig; Amanda D French; Tura C Camilli; Brittany P Frank; Rachel Earley; Keith S Hoek; Joanne H Hasskamp; E George Elias; Dennis D Taub; Michel Bernier; Ashani T Weeraratna
Journal:  J Invest Dermatol       Date:  2009-01-29       Impact factor: 8.551

10.  Calpain activity is generally elevated during transformation but has oncogene-specific biological functions.

Authors:  N O Carragher; B D Fonseca; M C Frame
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.